Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Waters Corporation. (6/22/16). "Press Release: MultiModal Molecular Imaging Institute at Maastricht University Joins Waters Centers of Innovation Program". Milford, MA.

Organisations Organisation Waters Corporation (NYSE: WAT)
  Group Waters (Group)
  Organisation 2 Maastricht MultiModal Molecular Imaging Institute (M4I)
  Group Maastricht University (Universiteit Maastricht, UM)
Products Product mass spectrometry imaging (MSI) (MALDI imaging)
  Product 2 mass spectrometry (MS)
Index term Index term Waters–Univ Maastricht: mass spectrometry, 201606– collab M4I Institute joins Waters Centers of Innovation Program
Persons Person Heeren, Ron M. A. (Maastricht Univ 2015 Co-Director of M4I Institute before FOM Amsterdam 200808)
  Person 2 Fotheringham, Eric (Waters 201410 Director Waters Centers of Innovation Program)
     


Institute Develops Medical Applications for Mass Spectrometry to Understand the Molecular Underpinnings of Cancer and Other Diseases


At a ceremony and symposium at Maastricht University, The Netherlands, Waters Corporation (NYSE:WAT) officially welcomed the Maastricht MultiModal Molecular Imaging Institute M4I into the Waters Centers of Innovation (COI) Program. Under the direction of Professor Ron Heeren, the institute conducts research into applications for mass spectrometry in three main areas: oncology, neurology and cardiovascular medicine.


[Photo]

On hand to congratulate Maastricht University and Prof. Heeren were (l-to-r) Davy Petit, Senior Director, Marketing, Europe, Middle East, Africa, India, Waters Corporation; Prof. dr. Ron Heeren, Maastricht University; Prof. dr. Martin Paul, President, Maastricht University; Marja van Dieijen, President and CEO of the Executive Board, Maastricht University, and Eric Fotheringham, Director - Strategic Collaboration, Waters Corporation.


“In 2014, we welcomed Ron Heeren in Maastricht to become our university professor. The economy of Limburg benefits greatly from his innovative impulses to scientific developments and Prof. Heeren’s research group is of paramount importance for the growth and development of UM research,” said Prof. Martin Paul, President of Maastricht University. “The M4I Institute, consisting of Heeren’s mass spectrometry lab and Peter Peters’s nanoscopy lab, is already one of the largest imaging centres in Europe. M4I expands already established imaging infrastructures such as Brains Unlimited, and improves Maastricht’s position as an international centre of excellence for human and molecular imaging even further.”

“Prof. Heeren is a true visionary and we are extremely pleased to welcome him into our COI Program,” said Eric Fotheringham, Director of the Waters Centers of Innovation Program. “The fantastic work being done by the MultiModal Molecular Imaging Institute with the help of imaging mass spectrometry gives me a lot of optimism about medical science and the future of health care.”

For its research, the Institute employs three forms of mass spectrometry – mass spectrometry imaging (MSI) coupled with ion mobility and high spectral mass resolution. The scope of Prof. Heeren’s use of imaging mass spectrometry is wide-ranging. He uses it to determine where molecules of all types – lipids, intact proteins, endogenous peptides, drug metabolites – are localized within a tissue sample - and which are found in high concentrations and which are not - all in an effort to improve the understanding of disease progression and regression.

In an interview published in 2014, Prof. Heeren said, “I dare to predict that in ten years’ time, this imaging technique will be a standard diagnostic tool and patients will be assessed on their individual molecular status. We’re already well on the way in oncology, neurology and cardiovascular medicine.”

Precision or personalized medicine is the development of treatments that are attuned to the specific biology of an individual patient. More specifically, by understanding the molecular heterogeneity of tumors and their different cellular phenotypes, precise treatments can be formulated that offer a patient the best chance of a long and healthy life.

To salute the work of Prof. Heeren and the Maastricht MultiModal Molecular Imaging Institute, Waters Corporation sponsored a symposium titled Translational Imaging MS: Molecular Pathology Towards Precision Medicine. The event featured presentations by noted experts in imaging mass spectrometry including Markus Stoekli, Novartis Institutes for BioMedical Research; Prof. Klaus Dreisewerd University of Münster; Prof. Michel W. F. Nielen, Wageningen University; Dr. Liam McDonnell, Leiden University Medical Center; Professor Zoltan Takats, Imperial College.


About the MultiModal Molecular Imaging Institute

The M4I Division of Imaging Mass Spectrometry is one of the world leaders in high resolution molecular imaging of biological surfaces. The division targets the development and application of state-of-the-art mass spectrometry based molecular imaging approaches for biomedical cellular and tissue research. Main research aim for the coming years is to develop and apply mass spectrometry as a tool for personalized medicine.


About Waters Corporation (www.waters.com)

Waters Corporation (NYSE:WAT) develops and manufactures advanced analytical and material science technologies for laboratory dependent organizations. For more than 50 years, the company has pioneered a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis systems.

Waters is a trademark of Waters Corporation.


Waters Corporation

Brian J. Murphy, +1 508-482-2614
Public Relations
brian_j_murphy@waters.com

   
Record changed: 2016-07-01

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Waters (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px